This study is aimed at describing the clinical implications and survival-predicted functions of UNC93B1 in AML, and the potential interaction between AML blasts’ metabolism and innate immune response, considering the innate immune system such as innate immune cells and TLR signaling may overcome the current barriers in AML treatment. This evidence concerns the gene UNC93B1 and acute myeloid leukemia.